A new paper in eLife from the Cavalli Lab reveals that inhibiting ETBR function enhances axon regeneration and rescues the age-dependent decrease in axonal regenerative capacity, providing a potential avenue for future therapies.
Endothelin B receptor inhibition rescues aging-dependent neuronal regenerative decline
View Content